Inferra AI / Company / CLOV
Clover Health Investments, Corp. /De
CLOV · Financials
Last earnings Aug 5, 2026
Key results
Total revenuequarter
$478 million
Total revenues of $478 million, up 34% year-over-year Second quarter 2025 profitability metrics with GAAP Net loss of $11 million, Adjusted EBITDA of $17 million, and
SEC original ↗Clover Health Investments, Corp. /De — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Growthquarter
up 34%
Total revenues of $478 million, up 34% year-over-year Second quarter 2025 profitability metrics with GAAP Net loss of $11 million, Adjusted EBITDA of $17 million, and
SEC original ↗Clover Health Investments, Corp. /De — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Adjusted net incomequarter
$17 million
Adjusted Net income of $17 million
SEC original ↗Clover Health Investments, Corp. /De — Earnings release (8-K exhibit)EX-99Aug 5, 2025
AI analysis
Q2 2025 · reported Aug 5, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
The quarter in charts
Guidance ladder — revenue
Delivered vs the company's guided range
EX-99 · Aug 5, 2025 Guide as stated by the company; range and midpoint computed from the stated figure.
Headline figures
| Metric | Q2 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Total revenue | $478 million | — | — |
| Growth | up 34% | — | — |
| Adjusted net income | $17 million | — | — |
Guidance · company-stated
“(4) $50 million”
“(2)(4) $50 million”
Guidance stated in the release's Business Outlook table for full-year 2025; no direction stated — figures as stated in the table.
Capital allocation
In April 2026, the FASB issued ASU 2026-01, Equity (Topic 505): Initial Measurement of Paid-in-Kind Dividends on Equity-Classified Preferred Stock .
The amendments in this update require entities to initially measure paid-in-kind ("PIK") dividends on equity-classified preferred stock using the PIK dividend rate stated in the preferred stock agreement, rather than at fair value.
What changed vs last quarter
- Guide midpoint vs latest-quarter revenue +276.6% computed from stated figures
Event summary
ET to discuss its operating results and other business highlights
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
revenue: “revenue $1.800 billion”
Adjusted EBITDA: “Adjusted EBITDA (4) $50 million”
Adjusted Net income: “Adjusted Net income (2)(4) $50 million”
revenue (“full-year 2025”)
“revenue $1.800 billion”
Adjusted EBITDA (“full-year 2025”)
“Adjusted EBITDA (4) $50 million”
Adjusted Net income (“full-year 2025”)
“Adjusted Net income (2)(4) $50 million”
Guidance stated in the release's Business Outlook table for full-year 2025; no direction stated — figures as stated in the table.
Capital allocation
In April 2026, the FASB issued ASU 2026-01, Equity (Topic 505): Initial Measurement of Paid-in-Kind Dividends on Equity-Classified Preferred Stock .
SEC original ↗Clover Health Investments, Corp. /De — 10-Q Quarterly report10-QAug 7, 2026
The amendments in this update require entities to initially measure paid-in-kind ("PIK") dividends on equity-classified preferred stock using the PIK dividend rate stated in the preferred stock agreement, rather than at fair value.
SEC original ↗Clover Health Investments, Corp. /De — 10-Q Quarterly report10-QAug 7, 2026
government and government agencies and authorities $ 16,669 $ ( 38 ) $ 14,626 $ ( 331 ) $ 31,295 $ ( 369 ) Corporate debt securities 13,733 ( 11 ) 13,733 ( 11 ) Total $ 30,402 $ ( 49 ) $ 14,626 $ ( 331 ) $ 45,028 $ ( 380 ) Number of positions 24 9 33 The Company did no t record any credit allowances for debt securities that were in an unrealized loss position at June 30, 2026 and December 31, 2025.
SEC original ↗Clover Health Investments, Corp. /De — 10-Q Quarterly report10-QAug 7, 2026
Strategy & priorities
We are executing our growth strategy well, and have generated significant momentum in our business this year during a 3.5 Star payment year.
SEC original ↗Clover Health Investments, Corp. /De — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Forward-looking statements include statements regarding future events and Clover Health's future results of operations, financial condition, market size and opportunity, business strategy and plans, and the factors affecting our performance and our objectives for future operations.
SEC original ↗Clover Health Investments, Corp. /De — Earnings release (8-K exhibit)EX-99Aug 5, 2025
In some cases, you can identify forward looking statements because they contain words such as may, will, should, expects, plans, anticipates, going to, can, could, should, would, intends, target, projects, contemplates, believes, estimates, predicts, potential, outlook, forecast, guidance, objective, plan, seek, grow, if, continue or the negative of these words or other similar terms or expressions that concern Clover Health's expectations, strategy, priorities, plans or intentions.
SEC original ↗Clover Health Investments, Corp. /De — Earnings release (8-K exhibit)EX-99Aug 5, 2025
This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare.
SEC original ↗Clover Health Investments, Corp. /De — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease.
SEC original ↗Clover Health Investments, Corp. /De — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Risks & headwinds
These statements are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by forward-looking statements in this press release.
SEC original ↗Clover Health Investments, Corp. /De — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Legal Proceedings 37 Item 1A.
SEC original ↗Clover Health Investments, Corp. /De — 10-Q Quarterly report10-QAug 7, 2026
These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the risk factors described in Part II, Item 1A, Risk Factors of this Quarterly Report on Form 10-Q.
SEC original ↗Clover Health Investments, Corp. /De — 10-Q Quarterly report10-QAug 7, 2026
In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.
SEC original ↗Clover Health Investments, Corp. /De — 10-Q Quarterly report10-QAug 7, 2026
We caution you that the foregoing list of judgments, risks, and uncertainties that may cause actual results to differ materially from those in the forward-looking statements may not be complete.
SEC original ↗Clover Health Investments, Corp. /De — 10-Q Quarterly report10-QAug 7, 2026
We obtained the industry, market, and similar data set forth in this Quarterly Report on Form 10-Q from our own internal estimates and research and from industry research, publications, surveys, and studies conducted by third parties, including governmental agencies, and such information is inherently subject to uncertainties.
SEC original ↗Clover Health Investments, Corp. /De — 10-Q Quarterly report10-QAug 7, 2026
Earnings deck slides
0 decks with slide viewClover Health Investments, Corp. /De — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Clover Health Investments, Corp. /De — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
31 documentsEarnings releases
7 documentsPresentations
2 documents
Transcripts
0 documentsNo transcripts for Clover Health Investments, Corp. /De are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.